ERCC2 and cancer: Because of the biological significance of XPD, XPD polymorphisms have been extensively studied in different malignant diseases, such as pancreatic (Wu et al., 2017), colorectal (Ni et al., 2014) and gallbladder (Srivastava et al., 2010) cancers.